Profound Medical Expects Q3 Revenue to Surpass Estimates by Nearly Half
Profound Medical (PROF) announced preliminary results for the third quarter, projecting revenue between $9.8 million and $10.0 million. This represents a significant increase of 85%-89% year-over-year and an impressive jump of 292%-300% compared to Q2 figures. The projected revenue is expected to exceed the Bloomberg consensus estimate by approximately 45%-47%, reaching well above $6.78 million. Additionally, the company anticipates a gross margin exceeding 70%. These results highlight strong performance and growth momentum for Profound Medical in its latest quarter.
Topics: Gross Margin Guidance Revenue
Read the full article at Seeking Alpha
Part of the story Profound Medical Expects Q3 Revenue to Surpass Estimates by Nearly Half (3 articles)